Click on the "Follow" button below and you'll get the latest news from NeuroEndocrine Cancer Australia via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
NeuroEndocrine Cancer Australia title: NeuroEndocrine Cancer Australia
Is this your feed? Claim it!
We are proud to share that our CEO, Meredith Cummins, has been appointed President of the International Neuroendocrine Cancer Alliance (INCA). Meredith has served on the INCA Board for two years and has been Chair of the Research Committee since 2024. In her new role, she will help lead a global network of patient organisations […]
The post
Thank you to NET patient Kristen Leknius for hosting a neuroendocrine cancer information table at the February Peninsula Bays Hospital Wellness Day. With around 250 people attending across the day, the event provided an important opportunity to share information about neuroendocrine cancers and increase awareness of NETs. Having NETs represented alongside other health and wel...
Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer Day, I wait for the noise. The headlines about how far we have come in cancer care, the announcements of new investments, and the outpouring of support for the cancers […]
...NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on the effectiveness of technology-enabled (p)rehabilitation interventions in individuals undergoing thoracic and/or abdominopelvic cancer surgery. Specifically, we assessed their impact on reducing postoperative ...
The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital, Peter MacCallum Cancer Centre, The Royal Brisbane and Women’s Hospital, and Fiona Stanley Hospital—there are currently 151 patients enrolled in the trial. Of these, 69 participants are in the intervention […]
<...